申请人:SPOFA
Spojené Podniky Pro Zdravotnickou Vyrobu
公开号:EP0396827A1
公开(公告)日:1990-11-14
N,N-Dimethyl-2-(3-hydroxyphenylthio)benzylamine and its acid addition salts possess properties of highly selective inhibitors of 5-hydroxytryptamine re-uptake in mammalian brain structures and are expected to find therapeutic use as potent central antidepressants. This novel compound and its intermediate, the 3-methoxyphenylthio analog, are available by per se known preparative routes, especially by reduction of the corresponding amides with hydride agents, by Leuckart reaction of 2-arylthiobenzaldehydes with dimethylformamide and formic acid, or by demethylation of the respective methoxy compound by means of e.g. pyridine hydrochloride or hydrobromic acid.
N,N-二甲基-2-(3-羟基苯硫基)苯乙胺及其酸盐加合物具有高度选择性地抑制哺乳动物脑结构中的5-羟色胺再摄取的特性,预计可作为有效的中枢抗抑郁剂用于治疗。这种新型化合物及其中间体,即3-甲氧基苯硫基类似物,可通过已知的制备路线制备,特别是通过用氢化剂还原相应的酰胺,通过Leuckart反应将2-芳基硫代苯甲醛与二甲基甲酰胺和甲酸反应,或通过使用吡啶盐酸盐或氢溴酸对相应的甲氧基化合物进行脱甲基化制备。